Evidence map›Paper›PMID 31149055›Full record

ArticleActa endocrinologica (Bucharest, Romania : 2005)

PLASMATIC LEVELS OF NEUROPEPTIDES, INCLUDING OXYTOCIN, IN CHILDREN WITH AUTISM SPECTRUM DISORDER, CORRELATE WITH THE DISORDER SEVERITY.

L Kobylinska, A M Panaitescu, G Gabreanu, C G Anghel, I Mihailescu, F Rad, C Nedelcu, I Mocanu, C Constantin, S V Badescu and 5 more

Open access · greenAbstract read
In one paragraph

Article in Acta endocrinologica (Bucharest, Romania : 2005). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Neurochemistry of Autism.Brain sciences · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

L Kobylinska"Prof. Dr. Al. Obregia" Clinical Psychiatry Hospital - Child and Adolescent Psychiatry, Bucharest, Romania.
A M PanaitescuFilantropia Hospital, Bucharest, Romania.
G Gabreanu"Victor Babes" National Institute of Research-Development in the Pathology Domain and Biomedical Sciences - Dept. of Immunohistochemistry, Bucharest, Romania.
C G Anghel"Prof. Dr. Al. Obregia" Clinical Psychiatry Hospital - Child and Adolescent Psychiatry, Bucharest, Romania.
I Mihailescu"Prof. Dr. Al. Obregia" Clinical Psychiatry Hospital - Child and Adolescent Psychiatry, Bucharest, Romania.
F Rad"Prof. Dr. Al. Obregia" Clinical Psychiatry Hospital - Child and Adolescent Psychiatry, Bucharest, Romania.
C Nedelcu"Prof. Dr. Al. Obregia" Clinical Psychiatry Hospital - Child and Adolescent Psychiatry, Bucharest, Romania.
I Mocanu"Prof. Dr. Al. Obregia" Clinical Psychiatry Hospital - Child and Adolescent Psychiatry, Bucharest, Romania.
C Constantin"Victor Babes" National Institute of Research-Development in the Pathology Domain and Biomedical Sciences - Dept. of Immunology, Bucharest, Romania.
S V Badescu"Carol Davila" University of Medicine and Pharmacy - Division of Physiology and Fundamental Neuroscience, Bucharest, Romania.
I Dobrescu"Prof. Dr. Al. Obregia" Clinical Psychiatry Hospital - Child and Adolescent Psychiatry, Bucharest, Romania.
M Neagu"Victor Babes" National Institute of Research-Development in the Pathology Domain and Biomedical Sciences - Dept. of Immunology, Bucharest, Romania.
O I GeicuUniversity of Bucharest, Faculty of Biology, Dept. of Biochemistry and Molecular Biology, Bucharest, Romania.
L Zagrean"Carol Davila" University of Medicine and Pharmacy - Division of Physiology and Fundamental Neuroscience, Bucharest, Romania.
A M Zagrean"Carol Davila" University of Medicine and Pharmacy - Division of Physiology and Fundamental Neuroscience, Bucharest, Romania.
Carol Davila University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextOxytocin has been investigated as a potential medication for psychiatric disorders. OBJECTIVE AND

designThis study prospectively investigates correlations between oxytocin and other neuropeptides plasma levels in patients with autism spectrum disorders (ASD) according to severity and treatment, as compared to controls. SUBJECTS AND

methodsThirty-one children (6 neurotypical as control) participated in this study. The patients were classified into mildly and severely-affected, according to Autism Diagnostic Observation Schedule (ADOS) scores. Oxytocin, orexin A and B, α-MSH, β-endorphins, neurotensin and substance P were investigated using a quantitative multiplex assay or a competitive-ELISA method.

resultsPlasma oxytocin levels differed between the groups (F (2, 24) =6.48, p=0.006, η2=0.35, observed power=86%): patients with the mild ASD had higher values of plasma oxytocin than those with the severe form (average difference=74.56±20.74pg/mL, p=0.004).

conclusionsThese results show a negative correlation between plasma levels of oxytocin and the severity of ASD and support the involvement of oxytocinergic mechanisms in ASD.

Indexed as

autismendorphinorexinoxytocin

Identifiers

PMID31149055
PMCPMC6535330
OpenAlexW2946838445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.